Cargando…
Mechlorethamine Gel Usage in Patients with Mycosis Fungoides in a Lymphoma Clinic
Autores principales: | Duffy, Robert, Jennings, Tara, Sahu, Joya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292456/ https://www.ncbi.nlm.nih.gov/pubmed/32565576 http://dx.doi.org/10.4103/ijd.IJD_433_18 |
Ejemplares similares
-
Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience
por: GARCIA-SALEEM, Tiffany J., et al.
Publicado: (2021) -
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
por: Liner, Kendall, et al.
Publicado: (2018) -
Gelling Your Dermatology Nursing Practice: A Practical Guide for Managing the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel
por: McCann, Sue A., et al.
Publicado: (2016) -
Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis
por: Gilmore, Elaine S., et al.
Publicado: (2020) -
Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
por: Crimp, Caitlin, et al.
Publicado: (2022)